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human blood through transcriptome
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David T. Pride 1, 3*
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Many pathogenic bacteria have bacteriophage and other mobile genetic elements whose
activity during human infections has not been evaluated. We investigated the gene
expression patterns in human subjects with invasive Methicillin Resistant Staphylococcus
aureus (MRSA) infections to determine the gene expression of bacteriophage and
other mobile genetic elements. We developed an ex vivo technique that involved direct
inoculation of blood from subjects with invasive bloodstream infections into culture media
to reduce any potential laboratory adaptation. We compared ex vivo to in vitro profiles
from 10 human subjects to determine MRSA gene expression in blood. Using RNA
sequencing, we found that there were distinct and significant differences between ex vivo
and in vitroMRSA gene expression profiles. Among themajor differences between ex vivo
and in vitro gene expression were virulence/disease/defense and mobile elements. While
transposons were expressed at higher levels ex vivo, lysogenic bacteriophage had
significantly higher in vitro expression. Five subjects had MRSA with bacteriophage that
were inhibited by the presence of blood in the media, supporting that the lysogeny state
was preferred in human blood. Some of the phage produced also had reduced infectivity,
further supporting that phage were inhibited by blood. By comparing the gene expression
cultured in media with and without the blood of patients, we gain insights into the specific
adaptations made by MRSA and its bacteriophage to life in the human bloodstream.
Keywords: Staphylococcus aureus, transcriptome, RNA Seq, human microbiome, bacteriophage, prophage,
mobile genetic element
Introduction
Staphylococcus aureus is a pathogen that is also considered normal human flora, and often takes
advantage of breaks in protective skin barriers to cause disease (Chaffin et al., 2012). While
S. aureus strains were primarily treatable with beta-lactam antibiotics in the past, their widespread
use has resulted in the emergence of Methicillin-Resistant S. aureus (MRSA) strains. MRSA can
be acquired in hospital- or community-based settings, but many of the Community-Acquired
MRSA (CA-MRSA) strains have replaced more traditional Hospital-Acquired (HA-MRSA) strains
in both environments (Shopsin et al., 2003; Popovich et al., 2008; Kennedy et al., 2010). CA-MRSA
generally has been responsible for many invasive soft tissue infections, and has several virulence
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factors including Panton-Valentine leukocidin (PVL), which are
thought to contribute greatly to its pathogenesis. PVL, which is
not regularly detected in Hospital Acquired (HA)-MRSA strains,
have been associated with epidemics of several CA-MRSA strains
in the United States (Pan et al., 2003; Vandenesch et al., 2003).
Virulence factors are of particular interest in invasive blood-
stream infections, and many are derived from mobile genetic
elements, including plasmids, bacteriophage, transposons, and
pathogenicity islands (Bae et al., 2006; Baba et al., 2008; Diep
et al., 2008b).
There usually are bacteriophage integrated into the genomes
of S. aureus isolates, with most of them belong to the phage
family Siphoviridae (Canchaya et al., 2003; Feng et al., 2008).
These phage are of intermediate size (generally around 40 to
45 kb) and often carry toxins that may contribute to patho-
genesis (Brussow et al., 2004). Some phage carry the immune
modulator staphylokinase, which is responsible for host tissue
destruction. Others encode toxins such as PVL, or superanti-
gens involved in toxic shock syndrome, necrotizing fasciitis, and
food poisoning (Deghorain and Van Melderen, 2012). These
phage likely impact staphylococcal pathogenesis through lyso-
genic conversions, where the virulence functions they carry
are expressed during infection in humans. The expression of
these phage may directly reflect their contributions to patho-
genesis, but has not been thoroughly examined during human
bloodstream infections.
The expression of genes involved in the pathogenicity of CA-
MRSA has been mainly studied in vitro (Cui et al., 2005; Lindsay
et al., 2006; Stevens et al., 2007; Pohl et al., 2009). Few studies
have compared the in vivo and in vitro gene expression of MRSA,
and generally have been restricted to animal models (Diep et al.,
2008a,b; Chaffin et al., 2012), which may not fully reflect the
adaptive behavior of the pathogen in humans. Other ex vivo
strategies have grown a single, lab-adapted MRSA strain in the
presence of healthy human donor blood to characterize virulence
genes that may be overexpressed (Malachowa and Deleo, 2011;
Malachowa et al., 2011). No studies, however, have studiedMRSA
across human subjects with varying degrees of illnesses to under-
stand whether the behavior of MRSA and their mobile genetic
elements is reproducible across different human subjects. It is of
substantial importance to understand the contributions of phage
and other mobile genetic elements to MRSA pathogenesis during
human infections and their potential for spread to others.
The primary tool for analysis of global patterns of gene
expression in microbes is transcriptomics. While some have
studied transcriptomics in MRSA utilizing quantitative PCR
(Sabersheikh and Saunders, 2004), or microarray analysis (Wit-
ney et al., 2005; Lindsay et al., 2006), RNA sequencing pro-
vides a tool for characterization of patterns of gene expression
that does not require a priori information about the pathogen
being studied (Wilhelm and Landry, 2009). Thus, gene expres-
sion patterns from RNA sequencing can be used to thoroughly
characterize novel MRSA strains. RNA sequencing technology
has not been employed to characterize global changes in S. aureus
gene expression in humans with invasive bloodstream infec-
tions. Here, we report the RNA sequencing expression profiles of
MRSA strains grown in the presence of blood from 10 human
subjects with invasive bloodstream infections and characterize
differences observed in the expression of bacteriophage and other
mobile genetic elements by comparing expression profiles with
and without human blood.
Results
Human Subjects and RNA Enrichment
We sampled blood from 10 human subjects with invasive blood-
streamMRSA infections (Table 1 and Supplemental Table 1), and
cultured each to further our understanding of the gene expres-
sion of MRSA in the human bloodstream. We utilized an ex vivo
technique that involved direct inoculation at the bedside of blood
from human subjects with invasive bloodstream infections into
culture media that bypassed the need for a separate in vitro
culture step; thus, the isolates from each subject were charac-
terized directly from blood with minimal opportunity for gene
expression changes that might accompany laboratory adapta-
tion. The cohort of subjects in this study included many that
were critically-ill (Table 1), which significantly contrasts with a
prior study characterizing a single lab-adapted MRSA strain cul-
tured in the presence of blood from healthy donors (Malachowa
et al., 2011). For comparison, we performed a separate isola-
tion of each MRSA strain, and cultured each in vitro to help
decipher comparatively those genes whose expression might be
induced through exposure to the human bloodstream. Samples
21MRA and 23MRA were isolated from the same individual
48 h apart, and were utilized to help determine whether results
would be consistent within individual subjects over time. All
ex vivo and in vitro MRSA isolates were grown to log phase
(Supplemental Figure 1), and total RNA was isolated from each
subject/MRSA isolate under both growth conditions. Because the
ex vivo samples were cultured in the presence of blood from
each human subject, we enriched to remove any RNA that may
have been derived from the human host. The resulting RNA was
sequenced from all 10 subjects for a total of 6,213,492 ex vivo
reads (mean of 564,863 ± 79,540 per subject) and 4,568,420
in vitro reads (mean of 415,310 ± 10,582 per subject) (Table 2).
The inclusion of the enrichment step substantially reduced the
presence of human RNA, as exemplified by the relatively low per-
centage of RNA identified that was homologous to human DNA
(mean 1.22 ± 0.55%; range from 0.17% to 6.26%). All sequence
reads homologous to human DNAwere removed prior to further
analysis.
Identification of Staphylococcal Sequence Reads
We mapped the sequence reads from each subject to a
database of known staphylococcal genomes (available at
ftp://ftp.ncbi.nlm.nih.gov/genomes/Bacteria/) to determine
whether we could identify gene sequences from the Staphylo-
coccus genome that were expressed upon exposure to human
blood. We found that the vast majority of the ex vivo sequenced
reads mapped to known staphylococcal genomes (mean 98.78 ±
0.32%), with a similar proportion of the in vitro sequenced
reads (98.06 ± 0.19%) also mapping to known staphylococcal
genomes. That a similar percentage of ex vivo and in vitro
sequenced reads mapped to staphylococcal genomes, indicates
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TABLE 1 | Study subjects.
Age Sex Diagnosis Comorbidities Antibioticsa
1MRA 64 Male Bacteremia; severe sepsis; abscess Quadriplegia; hypertension Vancomycin/Gentamicin/Rifampin
3MRA 57 Female Bacteremia; sepsis Metastatic colon cancer Vancomycin
4MRA 84 Female Bacteremia; sepsis; infected dialysis graft End-stage renal disease Vancomycin/Gentamicin/Televancin
6MRA 64 Female Bacteremia; septic arthritis Metastatic colon cancer Vancomycin
20MRA 60 Male Bacteremia; sepsis; furunculosis Asthma Vancomycin
21/23MRAb 50 Male Bacteremia; sepsis; line infection Dermatomyositis Vancomycin/Daptomycin
31MRA 60 Female Bacteremia; severe sepsis Schleroderma Vancomycin/Piperacillin/Tazobactam
55MRA 60 Female Bacteremia; sepsis; line infection Congestive heart failure Vancomycin/Rifampin
74MRA 81 Male Bacteremia; sepsis; Pneumonia High blood pressure Vancomycin/Piperacillin/Tazobactam
256MRA 73 Female Bacteremia; sepsis; osteomyelitis T12 paraplegia; sacral decubitus ulcer Vancomycin/Piperacillin/Tazobactam
aAntibiotics administered within 24 h prior to the sample collection.
bSubjects 21 and 23 represent the same individual for which samples were collected at different time points.
TABLE 2 | RNA sequences from all subjects.
Reads Average length Homologous to human genome After trimming Reads mapping to S.aureus (%) Top genome
EX VIVO
1 MRA 505,449 103 27,413 437,829 427,847 (97.72) S. aureus COL
3 MRA 1,266,504 106 3447 1,166,335 1,164,602 (99.85) S. aureus COL
4 MRA 1,023,554 105 490 880,026 878,868 (99.87) S. aureus JH1
6 MRA 630,865 104 11,848 575,675 571,640 (99.30) S. aureus USA300
20 MRA 336,473 105 1432 289,966 287,842 (99.27) S. aureus JH1
*21 MRA 766,395 107 8330 681,855 674,333 (98.90) S. aureus USA300
*23 MRA 583,685 104 9419 464,855 459,591 (98.87) S. aureus USA300
31 MRA 657,978 100 3419 596,716 595,028 (99.72) S. aureus COL
55 MRA 489,670 96 585 298,828 289,039 (96.72) S. aureus JH1
74 MRA 478,942 107 1129 410,085 405,586 (98.90) S. aureus USA300
256 MRA 443,073 108 71 411,322 400,666 (97.41) S. aureus USA300
IN VITRO
1 MRA 479,683 105 2 404,995 397,930 (98.26)
3 MRA 532,094 110 1 481,800 466,891 (96.91)
4 MRA 474,698 108 0 414,247 407,187 (98.30)
6 MRA 454,227 111 1 414,825 402,384 (97.00)
20 MRA 442,793 105 2 403,797 399,087 (98.83)
*21 MRA 440,061 106 8 408,518 401,531 (98.29)
*23 MRA 466,089 109 2 444,640 434,200 (97.65)
31 MRA 465,569 107 1 392,500 386,082 (98.36)
55 MRA 401,893 100 4 357,369 349,760 (97.87)
74 MRA 514,879 110 4 460,010 453,521 (98.59)
256 MRA 449,617 107 2 385,719 380,309 (98.60)
*Subjects 21 and 23 represent the same individual for which samples were collected at different time points.
the enrichment process was highly specific for bacterial RNA.
Four of the 10 subjects likely harbored MRSA USA300 type
strains based on their high percentage of mapping reads, while
the other six subjects harbored strains that mapped to more
traditional HA-MRSA strain types. Both samples 21MRA and
23MRA mapped to USA300 strains, indicating that this strain
type was identical over the 48 h between samplings in that
individual subject.
Ex Vivo vs. In Vitro MRSA Gene Expression
Profiles
We examined the overall gene expression from each subject both
ex vivo and in vitro to determine whether there were global
differences in gene expression that might signal adaptations to
human blood. We found that there was a significant difference
in the proportion of MRSA genes expressed, with far fewer
genes expressed ex vivo (47.88 ± 5.39% ex vivo vs. 60.82 ±
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FIGURE 1 | Global gene expression of Staphylococcus aureus
cultured in blood from human subjects (ex vivo) and in vitro.
(A)—mean percentage (± standard error) of total genes expressed
ex vivo and in vitro. (B) —heatmap of gene expression profiles ex vivo
and in vitro for all subjects. Each column represents an individual
subject, and each row represent each individual S. aureus gene. The
most highly expressed genes are shown in yellow, while genes that are
not expressed (RPKM value of 0) are shown in black. A dendrogram
representing the hierarchical clustering of each subject is shown below
the heatmap.
FIGURE 2 | Principal coordinates analysis of Staphylococcus aureus
transcriptomes ex vivo (black squares) and in vitro (white circles). Beta
diversity was determined using binary Sorensen distances based on RPKM
values, and was used as input for the principal coordinates analysis.
1.07% in vitro; p = 0.028) (Figure 1A). As demonstrated by
heatmap, many subjects had relatively limited global gene expres-
sion profiles ex vivo when compared to their in vitro counter-
parts (Figure 1B). Samples 21MRA and 23MRA from the same
subject demonstrated similar but not identical patterns of gene
expression. Overall, MRSA strains had patterns of gene expres-
sion that were reflective of either their ex vivo or in vitro envi-
ronment (Figure 1B), suggesting that the limited patterns of gene
expression ex vivo directly reflected adaptations to human blood.
These data also were supported by principal coordinates analysis,
which showed that much less heterogeneity amongst the in vitro-
derived specimens than was observed for the ex vivo specimens
(Figure 2).
Subsystem Specific Gene Expression in MRSA
We compared MRSA subsystem gene expression profiles to
determine whether there were specific differences attributable to
culture in media with human blood. There were significant dif-
ferences (p = 0.05) in ex vivo and in vitro gene expression
in numerous subsystems, including virulence/disease/defense,
and mobile genetic elements among other subsystems identified
(Supplemental Figure 2). In 9 of the 10 subjects studied, there
was higher ex vivo expression of mobile elements than in vitro
(Supplemental Figure 3), and significantly greater expression of
prophage genes in vitro than ex vivo (Figure 3). Expression of
beta lactamases involved in resistance to beta lactam antibi-
otics also was significantly increased on transposons (Tn552;
p = 0.007) and on plasmids (p = 0.003). We found no sig-
nificant differences in expression of the mecA penicillin bind-
ing protein gene, which also encodes resistance to beta lactam
antibiotics.
We also examined the expression of virulence subsystems
in MRSA ex vivo and in vitro to determine the impact of cul-
ture in media with human blood on MRSA virulence gene
expression. We found that in seven of the 10 subjects stud-
ied, virulence gene expression was higher in vitro than ex vivo
(Supplemental Figure 4), which suggests that human blood may
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have inhibitory effects on the expression of certain virulence
genes. Despite the generally lower expression of virulence genes,
some were more highly expressed ex vivo, including Staphy-
lococcus aureus pathogenicity islands (SAPIs) and cytolysins
(Supplemental Figure 5A). SAPIs are highly diverse phage-
related chromosomal islands that insert into the genome at
distinct sites (Novick and Subedi, 2007), while cytolysins gen-
erally are involved in the lysis of neutrophils (Queck et al.,
2009). Only five of the MRSA isolates encoded PVL (lukS/F-
PV), which was more highly expressed ex vivo, although
the difference was not statistically significant (p = 0.120)
(Supplemental Figure 5B).
Because of the high expression of beta lactamases despite the
absence of beta lactam therapy in most subjects, we focused
on the potential response of MRSA to other antibiotics. Each
subject had been treated with vancomycin (a glycopeptide
antibiotic that disrupts the cell wall of MRSA through the
prevention of cross-linking at terminal d-alanine moieties). We
found no significant difference in the expression of ddl, which
encodes d-alanine moieties (Supplemental Figure 5B). tcaA also
is involved in the response to glycopeptide antibiotics (Srinivasan
et al., 2002), and was more highly expressed in all study subjects
ex vivo, although the difference was not statistically significant
(p = 0.101).
FIGURE 3 | Mean percentage (± standard deviation) of mobile element
gene expression devoted to specific elements. Mobile genetic element
relative abundances were determined based on the proportion of each
selected mobile element to the total mobile genetic element RPKM values.
Mobile genetic elements were determined based on homologies to gene
categories in the SEED database. p-values are shown above each mobile
element. Ex vivo gene expression is represented by black bars and in vitro is
represented by white bars.
Prophage Expression Inhibited by Culture in
Media with Blood
Because of the significantly higher expression of mobile genetic
elements ex vivo (Supplemental Figure 3), and the greater
expression of prophage genes in vitro (Figure 3), we investigated
whether there may be specific differences identified in bacterio-
phage gene expression in vitro and ex vivo. There were signif-
icant differences in the expression of phage repressors, which
were significantly more highly expressed ex vivo (p = 0.039)
(Figure 4). Similarly, we also found high expression of phage
anti-repressors in vitro, although those differences were not sta-
tistically significant (p = 0.238). The higher expression of repres-
sors and antirepressors ex vivo and in vitro, respectively, sug-
gests that there were specific interactions with human blood
that resulted in inhibition of prophage progression to lytic gene
expression.
To test whether culture in media with human blood was
inhibitory to prophage expression, we stimulated prophage using
mitomycin C in each of the 11 isolated MRSA strains. We
found that 6 of the 11 strains produced viable phage in Brain
Heart Infusion broth (BHI) in the presence of mitomycin C
(including strains 3MRA, 20MRA, 21MRA, 23MRA, 74MRA,
and 256MRA); however, the production of phage was inhibited
FIGURE 4 | Mean percentage (± standard deviation) of mobile element
gene expression devoted to bacteriophage repressors and
anti-repressors. Repressor/antirepressor relative abundances were
determined based on the proportion of each repressor/antirepressor to the
total mobile genetic element RPKM values. Mobile genetic elements were
determined based on homologies to gene categories in the SEED database.
p-values are shown above each element. Ex vivo gene expression is
represented by black bars and in vitro is represented by white bars.
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in all six strains by the presence of human blood in culture media
(Figure 5A). Interestingly, there was spontaneous induction of
phage in strains 3MRA and 20MRA, but the number of phage
were two to three logs lower than were produced in the presence
of mitomycin C. We also tested whether the reduction in phage
identified in the presence of blood may be related to inhibition
of phage infectivity rather than a decrease in phage production.
We found that for both 3MRA and 23MRA there was a decrease
in observed PFUs by 1.5 to 2 logs, indicating that infectivity
was diminished in the presence of blood (Figure 5B). Because
phage adsorption has previously been shown to be inhibited by
immunoglobulins (Martin and White, 1968; Nordstrom et al.,
1974), it is likely that diminished adsorption was responsible for
the decrease in infectivity. The fact that infectivity was only par-
tially inhibited (Figure 5B) suggests the lack of PFUs produced in
culture with blood (Figure 5A) cannot be completely explained
by inhibition of adsorption. These data are highly suggestive that
expression and adsorption of these phage are inhibited by life in
the human bloodstream.
Identification of Inhibited Prophage
We sequenced the phage from subjects 3MRA and 23MRA to
determine which specific phage were inhibited in culture media
with blood. We isolated phage 3MRA and 23MRA starting from
single plaques, then purified and sequenced the DNA directly
from the virions. We produced a total of 241,857 reads for
phage 3MRA, of which 234,536 (97%) assembled into a single
42,141bp contig with 1177X average coverage (Figure 6A). We
also sequenced 216,080 reads for phage 23MRA, of which 197,211
(91%) assembled into a single 43,114bp contig with 961X aver-
age coverage (Figure 6B). Based on BLASTN analysis, there were
no nearly identical matches for phage 3MRA, but it was simi-
lar and shared synteny with S. aureus siphoviruses phiETA and
phiETA3 (Figure 7A). Phage 23MRA was virtually identical to a
prophage found in the genome of S. aureus USA300 TCH1516,
which also is closely related to S. aureus siphoviruses phage 77,
and phiETA2 (Figure 7B). Genome alignments shows that phage
23MRA hasmuch greater similarity to Phage 77 than to phiETA2.
Each phage sequenced had homologs to structural genes (head,
tail, and portal), replication machinery (polymerases), integra-
tion genes (integrases), lysis and packagingmachinery (lysins and
terminases), genes that control transcription (repressors/anti-
repressors), and virulence genes (toxin-antitoxin, complement
inhibitor, chemotaxis inhibitor, and staphylokinase). All ORFs
identified in phage 3MRA and 23MRA phage had homologs
to staphylococcal phage genes or genes previously identified
in staphylococcal genomes. These data specifically identify
prophage whose expression is inhibited by culture in media with
blood, and the profound similarity between these phage and
many previously identified staphylococcal prophage suggests that
they may also be inhibited by human blood.
Discussion
Staphylococcus aureus is highly prevalent and responsible for sub-
stantial morbidity and mortality. Its epidemiology has shifted,
resulting in methicillin-resistant strains having similar preva-
lence to methicillin-sensitive strains in clinical settings. Because
studies generally identify single MRSA genotypes from sterile
site infections (Young et al., 2004), most MRSA infections are
believed to be caused by single rather than multiple different
genotypes. There was no evidence based on the MRSA culture
data and susceptibility patterns of mixed infections in the 10
subjects studied. While much is known about its pathogenic-
ity, the in vivo gene expression of MRSA and its lysogenic
phage have yet to be thoroughly examined in humans. Our
FIGURE 5 | Production of phage from MRSA strains in the presence
of human blood, or BHI broth with and without mitomycin C (A), and
inhibition of infectivity of phage produced in human blood or BHI
broth (B). Mean plaque forming units (log) (± standard deviation) from three
separate experiments is demonstrated. In (A), BHI broth with and without
mitomycin C are represented by black and white squares, respectively, and
blood with and without mitomycin C are represented by black and white
triangles, respectively. In (B), phage 3MRA in the presence of BHI broth and
blood is represented by white and black squares, respectively, and phage
23MRA in the presence of BHI broth and blood is represented by white and
black circles, respectively. Standard deviation bars are demonstrated on
each panel.
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FIGURE 6 | Diagram of bacteriophage genomes sequenced from the
virions from Subjects 3MRA (A) and 23MRA (B). Putative ORFs and their
direction are indicated by the arrows. ORFs that had significant homologs
(BLASTP E-score <10−5) are indicated by the text above each arrow. In
(A), those ORFs that had synteny with Staphylococcus phage PhiETA2 are
labeled GP66, GP63, GP62, GP61, GP59, GP58, GP57, GP56, GP50,
GP35, GP33, GP14, and GP13. In (B), those ORFs that had synteny with
Staphylococcus phage PhiPVL are labeled ORF60, ORF39, ORF38, ORF22,
ORF21, ORF22, and ORF17. Putative functions for each ORF are labeled
when available. The length of each contig is denoted at the top of each panel.
technique for characterizing MRSA ex vivo gene expression was
unique in that it involved examining the gene expression of
MRSA cultured directly from the blood of different human sub-
jects with bloodstream infections without any separate in vitro
culture steps, followed by comparisons with in vitro growth
to identify differences that might be attributable to life in the
human bloodstream. While not technically an in vivo technique
because of the separate culture step, we identified numerous dif-
ferences between ex vivo and in vitro MRSA gene expression
profiles, with the lysogenic phage providing the most notable
differences. Although the group of subjects we studied was rel-
atively heterogeneous in their underlying comorbidities, each
had invasive MRSA bloodstream infections. The heterogeneity
in their comorbidities and individualized medical therapies may
be responsible for the variability observed in gene expression
from each subject (Figure 1). Because it took approximately 72 h
to identify those subjects who had MRSA bloodstream infec-
tions, most of the subjects enrolled in this study had either
cleared their bacteremia or were deceased by the time a diag-
nosis was made. This severely limited our ability to obtain
further specimens to test biological replicates. Because some
of the subjects were critically ill and treated with complex
antibiotic combinations (Table 1), the features of their immune
responses and antibiotic regimens would be difficult to repli-
cate in vitro, which further adds to the uniqueness of this cohort
and the responses of the MRSA isolates studied. The differences
in MRSA gene expression profiles observed cannot be solely
attributed to antibiotics, as there were different gene expression
profiles observed in subjects treated with the same antibiotic
regimens.
We were highly interested in the expression of mobile
genetic elements (including phage, plasmids, and transposons)
associated with bacterial infections in the human bloodstream,
as they may be the primary means by which new gene functions
are transmitted in nature. Beta lactamases expressed on mobile
elements ex vivo were significantly overexpressed compared to
in vitro (Figure 3), suggesting that their expression may be part
of the organism’s stress response to human blood. Because most
of the subjects studied were not treated with beta lactam antibi-
otics, the regulation of these beta lactamases likely is indepen-
dent of beta lactam therapy. While beta lactamases were more
highly expressed ex vivo, mecA expression was stable under each
growth condition. Because the MecA penicillin binding protein
is involved in the normal processing of the MRSA cell wall, its
expressionmight not be expected to be substantially altered when
cultured in media with human blood.
While there has been some prior analysis of the effect of
human blood on prophage (Gaidelyte et al., 2007), our ex vivo
data strongly suggest that repression of certain prophage is char-
acteristic of MRSA invasive bloodstream infections. This was
supported by the higher ex vivo expression of repressor genes
(Figure 4), which are essential for the inhibition of the phage
lytic genes. An inverse effect was noted in vitro, where the
higher expression of anti-repressor genes was indicative of the
expression of the phage lytic module. We were unable to place
the MRSA genomes into lineage groups (Lindsay et al., 2006;
McCarthy and Lindsay, 2010) based on the presence/absence
of mobile genetic elements because the heterogeneity in gene
expression and the potential for prior horizontal gene transfers
(McCarthy et al., 2012a,b) could have led to erroneous results.
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FIGURE 7 | Alignments of phage 3MRA (A) and phage 23MRA (B) with
various other known staphylococcal phage. The boxes represent
segments of each phage that are relatively well conserved amongst the
aligned phage and the lines between the boxes represent the relative position
of conserved segments of each phage in the different genomes. Diagonal
lines represent potential genome rearrangements. Relative locations in the
genomes of each phage are demonstrated by the nucleotide numbers above
each phage. The yellow lines represent the sites of the first nucleotide in the
assembled 3MRA and 23MRA phage contigs. Some phage segments
shown by the arrows contain conserved genes representing structural
elements, DNA metabolism, lysis, lysogeny, virulence, and regulation. The
height of the colors across each box represents the average conservation in
that phage segment across the phage examined. attP sites, which represent
the sites on phage genomes where they integrate into their host genomes,
are represented by blue boxes. attP sequences were not determined for
phage 3MRA and 23MRA.
There also was altered expression of site-specific recombinases
in this cohort, but their potential dual roles in integration and
excision complicates their interpretation (Hanssen and Ericson
Sollid, 2006; Malachowa and Deleo, 2010).
In addition to altered phage expression in response to blood
in culture media, we found that infectivity of the phage also was
diminished, likely through inhibition of adsorption (Figure 5)
(Martin and White, 1968; Nordstrom et al., 1974). These results
suggest that the transport and adsorption of phage particles,
as well as the transmission of phage-encoded genes, may be
restricted during MRSA bloodstream infections in humans. We
also identified certain phage that were specifically inhibited
by culture in media with human blood (Figure 6), and their
strong similarities to prophage found in other MRSA isolates
(Figure 7) suggests that they also may be inhibited by blood. Not
all MRSA isolates had produced phage particles that we could
detect using acceptor strain RN10950. We also utilized strain
RN4220 (a restriction deficient S. aureus strain cured of three
prophage) (Novick, 1967), but were unable to detect phage from
the other MRSA isolates. Our study differs significantly from a
prior study documenting the effects of human blood on staphy-
lococcal phage. In that study, the authors concentrated specifi-
cally on phage that were expressed during culture in media with
human blood (Gaidelyte et al., 2007), whereas our study identi-
fies those phage that were inhibited by culture with human blood.
Also, in contrast to that study, our data on these specific MRSA
phage shows that infectivity was diminished in the presence of
blood (Figure 5).
The production of viable phage from prophage in the MRSA
genomes in this study directly supported the RNA sequencing
data. We observed a substantial over-expression of phage repres-
sors ex vivo (Figure 4), which correlated directly with the inhibi-
tion of phage production in human blood (Figure 5). Although
most MRSA isolates in our study carried integrases, which often
indicate the presence of prophage, not all strains produced viable
prophage that we could detect with our acceptor strains. This sug-
gests that some of our MRSA strains carried prophage remnants
and/or cryptic prophage rather than viable prophage (Canchaya
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et al., 2003; Casjens, 2003). With the exception of isolate 6MRA,
most CA-MRSA strains produced viable phage, compared to
only one HA-MRSA strain (3MRA). The phage we identified
(Figure 6) had virulence genes such as staphylokinase (involved
in tissue destruction), toxin/antitoxin systems (may be involved
in defense, drug tolerance, programmed cell death, and growth
control) (Nolle et al., 2013), and genes for an immune escape
complex (involved in immune evasion) (Goerke et al., 2006),
which suggests that these phage may play several different roles
in MRSA pathogenesis.
Conclusions
While some studies have profiled S. aureus in vitro behavior (Ren-
zoni et al., 2006; Sass et al., 2008) and gene expression profiles in
mouse models (Allard et al., 2006; Chaffin et al., 2012), the gene
expression of their bacteriophage and other mobile genetic ele-
ments have not been examined in vivo. While our ex vivo model
includes a separate culture step, the blood culturing step was
absolutely necessary to first identify those human subjects that
had invasive bloodstream infections. The benefit of the model
was that we could isolate each strain in vitro, and thus discern
differences in bacteriophage and mobile genetic elements gene
expression profiles between ex vivo and in vitro that may have
represented adaptation to life in the human bloodstream. The
expression of mobile genetic elements was amongst the most
significant differences between gene expression profiles ex vivo
and in vitro, and these differences identified may have conse-
quences for the human host. From the over-expression of beta
lactamases on plasmids and transposons ex vivo, to the repression
of prophage expression and adsorption during culture in media
with human blood, differences in the expression ofmobile genetic
elements were characteristic of the MRSA ex vivo response.
As we continue to study the behavior of human pathogens,
ex vivo studies such as this provide further insights into the gene
expression patterns in pathogens and their viruses as they adapt
to life in the human host.
Materials and Methods
Ethics Statement
Human subject involvement in this study was approved by the
University of California, San Diego Administrative Panel on
Human Subjects in Medical Research. The study was certified
as category 4 exempt, which includes research involving the col-
lection or study of existing data, documents, records, patholog-
ical specimens, or diagnostic specimens, if the information is
recorded in such a manner that subjects cannot be identified,
directly or through identifiers linked to the subjects.
Human Subjects and Culture Conditions
We sampled blood from 10 human subjects with invasive blood-
stream infections (Table 1). Samples 21MRA and 23MRA were
taken from the same subject approximately 48 h apart for a total
of 11 different samples from 10 subjects. From each subject,
8–10mL of blood was inoculated directly at bedside into 30ml
of media in BD Bactec Plus aerobic culture vials (BD Diagnos-
tic Systems, Sparks, MD) and incubated for approximately 4–8 h
until positive by fluorescent detection using the Bactec FX sys-
tem (Zadroga et al., 2013). Positive cultures were gram stained,
grown on sheep blood agar plates, and subjected to a coagulase
test for a presumptive identification of Staphylococcus aureus.
Identification and susceptibility testing was performed using the
BD Phoenix system (Stefaniuk et al., 2003) to confirm the pres-
ence of MRSA in the bloodstream of each subject. Susceptibil-
ities were based on MIC (minimum inhibitory concentration)
breakpoints using Clinical and Laboratory Standards Institute
guidelines (CLSI, 2012). Each isolate was assayed for suscep-
tibility to antibiotics cefazolin, clindamycin, daptomycin, line-
zolid, oxacillin, rifampin, trimethoprim/sulfamethoxazole, and
vancomycin. Clindamycin susceptibility was verified by D-test
(Woods, 2009). A minimum of 3mL of each positive sample
in the standard aerobic culture vial was immediately processed
in the ex vivo arm of this study. For the in vitro growth con-
ditions, each identified MRSA strain was grown on blood agar
plates, and reconstituted in tryptic soy broth at an OD600 of 0.1.
One milliliter of this suspension was diluted in 7ml of sterile
normal saline and inoculated into the BD Bactec Plus aerobic cul-
ture vials and incubated for approximately 3–6 h until positive by
fluorescent detection using the Bactec FX system. One milliliter
of this suspension was immediately processed in the in vitro arm
of this study.
MRSA Growth Conditions
OD600 values for each isolate grown in the BD Bactec Plus aer-
obic vials was determined at the time of fluorescence detection
(approximately 3.5 to 4.5 h, depending on the isolate). To deter-
mine the growth phase at the time of fluorescence detection,
MRSA isolates were grown for 16 h in BD Bactec Plus aerobic
broth and reconstituted to an OD600 of 0.1. Cultures were then
incubated at 35◦C in BD Bactec Plus aerobic broth with gentle
agitation and OD600 values for each isolate was determined at
15min intervals over a 24 h period to construct growth curves.
CFU/mL for each isolate under in vitro conditions were deter-
mined by plating 100µL of serial dilutions onto BHI agar plates
and incubated at 35◦C for 16 h. Because the presence of the blood
prohibited us from using direct comparisons of OD600 values
between the ex vivo and in vitro cultures, we determined the
CFU/mL counts from each subject ex vivo to estimate the growth
phase at the time of fluorescence detection by plating 100µL of
serial dilutions on BHI agar plates. All ex vivo and in vitro cultures
were found to be in early to mid log phase at the time of detec-
tion. Two volumes of RNA protect (Qiagen, Valencia, CA) was
added directly to the cultures, and they were pelleted and stored
at−20◦C until RNA extraction.
RNA Extraction, Enrichment, and Sequencing
RNA from both the ex vivo and in vitro samples were pro-
cessed identically from all subjects and MRSA isolates. Total
RNA was extracted using the Mirvana kit (Life Technolo-
gies, Grand Island, NY), with the inclusion of a bead-beating
step for 20min with Lysing-Matrix B (MP Bio, Santa Ana,
CA). Total RNA then was enriched for microbial RNA using
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MicrobEnrich (Life Technologies), and further enriched for
mRNA using MicrobExpress (Life Technologies) and MegaClear
(Life Technologies), which are designed to remove ribosomal
RNAs. Enriched RNA then was prepared for sequencing through
the construction of cDNA libraries using the Ion Total RNA-
Seq kit (Life Technologies), and subjected to successive rounds
of Ampure bead purification (Beckman-Coulter, Brea, CA) to
remove small cDNAs. Libraries were quantified using an Agilent
Bioanalyzer HS DNA Kit (Agilent, Santa Clara, CA) and then
were sequenced on a 314 chips using an Ion Torrent Personal
Genome Machine (Rothberg et al., 2011), producing an average
of 559,129 reads per subject of mean length 106 nucleotides. All
sequence data produced in this study are available in the MG-
Rast database (metagenomics.anl.gov/) under the project name
“MRSA_RNAseq_Study” or project #2278.
Processing of RNA Sequences
Sequencing reads were trimmed according to modified Phred
quality scores of 0.5 using CLC Genomics Workbench 4.65
(CLC bio USA, Cambridge, MA). The remaining reads were
further processed for quality control by removing reads with
substantial length variation (reads <50 nucleotides or >200
nucleotides), or reads where ≥25% of the length was due
to homopolymers tracts. Each transcriptome was screened
for contaminating human nucleic acids using BLASTN anal-
ysis (E-score <10−5) against the human reference database
available at ftp://ftp.ncbi.nlm.nih.gov/genomes/H_sapiens/. Any
reads homologous to human sequences were removed prior to
further analysis. Both in vitro and ex vivo reads from each subject
were mapped to a database of staphylococcal genomes (avail-
able at ftp://ftp.ncbi.nlm.nih.gov/genomes/Bacteria/) to deter-
mine the percentage of reads that mapped to Staphylococcus and
to which individual strains they mapped best. Reads from each
subject mapped best to known MRSA genomes in all subjects
under each growth condition (Table 2).
Analysis of Transcriptomes
Each ex vivo and in vitro transcriptome were mapped against
USA300 MRSA strain FPR3757 using CLC Genomics Work-
bench 4.65. RPKM (reads per kilobase per million) values were
determined based on the read mappings, and values were nor-
malized for each subject and growth condition. A heatmap
demonstrating the distribution of gene expression based on
normalized RPKM values was generated using CLC Genomics
Workbench 4.65. Virtually identical heatmaps also were gener-
ated when reads were mapped against genomes of other MRSA
strains including COL, JH1, Mu50, TCH1516, and Newman.
RPKM values also were used as input for principal coordinates
analysis, and were performed based on binary Sorensen distances
using Qiime (Caporaso et al., 2010).
Analysis of gene expression from different subsystems in
MRSA were determined by blastX analysis of the SEED database
using MG-Rast (E-score <10−5) (Meyer et al., 2008). Mobile
genetic element and virulence gene expression was determined
based on the proportion of each selected mobile element or vir-
ulence gene to the total mobile genetic element or virulence
gene RPKM values. Subsystems such as mobile genetic elements
and virulence genes were determined based on homologies to
genes designated to those functions in the SEED database (Meyer
et al., 2008). Statistical significance was determined by compar-
ing the means for all subjects for all subsystems between the
ex vivo and in vitro subject groups by two-tailed t-tests using
Microsoft Excel 2007 (Microsoft Corp., Redman, WA). Analysis
of the expression differences between in vitro and ex vivo groups
for individual genes also were determined by comparisons of
means. The data for each individual gene were compared between
MG-Rast and the normalized RPKM values obtained from CLC
Genomics Workbench 4.65 to verify that they produced similar
results.
Prophage Stimulation and Sequencing
Each MRSA strain was grown in BHI broth (Becton, Dickinson,
MD, USA) for approximately 3 h at 37◦Cwith shaking at 200 rpm
to an OD600 of 0.5. The average number of cells was similar
between each MRSA strain (1.84 ± 0.45 × 108 Colony Forming
Units (CFU)/mL). Each strain then was centrifuged for 10min
at 10,000 rpm, pellets re-suspended in 500µL of BHI broth or
human blood (Novick, 1963), and mitomycin C added to a final
concentration of 2µg/mL. The human blood used was drawn
into heparin tubes (BD Diagnostic Systems, Sparks, MD) from
healthy donors. MRSA cultures without the addition of mito-
mycin C were used as experimental controls and were without
evidence of any prophage production, with the exception of iso-
lates 3MRA and 20MRA. Each was left for 16 h at 32◦C with
shaking at 50 rpm. To determine the number of phage produced,
cultures were centrifuged for 5min at 14, 000 rpm to remove cel-
lular debris, and filtered through 0.2µm pore membrane filters
(25mm, Whatman GE Healthcare Life Sciences). Supernatants
were cultured for the presence of any residual bacteria, and no
bacteria could be cultured from any. We tested the supernatants
for the presence of viable phage using the double layer method
(Novick, 1991). Briefly, S. aureus strain RN10950 (S. aureusNew-
man strain with all four prophage deleted) (Bae et al., 2006) was
grown for 4 h at 37◦C with shaking at 200 rpm to an OD600 of
1.0. Then, 100µL of S. aureus RN10950 and 100µL of the phage
supernatants were added to 3mL of phage top agar and poured
onto phage bottom agar plates (Novick, 1991). Plates were incu-
bated at 32◦C for 16 h and viral plaques were enumerated and
reported as Plaque Forming Units (PFU)/mL.
To determine if blood may inhibit phage infectivity, phage
3MRA and 23MRA were added to 1mL of BHI or fresh human
blood and incubated at 32◦C with shaking at 50 rpm to main-
tain the conditions used in induction experiments. Aliquots were
collected at 0, 4, and 16 h to determine the infectivity of phage.
Blood cells were removed prior to plating phage by centrifuga-
tion at 14,000 rpm for 5min and filtered through 0.45µm filters.
The phage in BHI also was centrifuged and filtered for consis-
tency. S. aureus strain RN10950 was grown for 4 h at 37◦C with
shaking at 200 rpm to anOD600 of 1.0. Then, 100µL of RN10950
and 100µL of BHI or blood containing the seeded phage were
serially diluted and added to 3mL of phage top agar and poured
onto phage bottom agar plates. Plates were incubated at 32◦C for
16 h and viral plaques were enumerated and reported as PFU/mL.
All experiments were performed in triplicate.
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Phage were isolated as previously described (Santiago-
Rodriguez et al., 2010). Briefly, viral plaques were retrieved using
a sterile pipette and placed in 500µL of 1× PBS. The plug was
dislodged using a sterile pipette and centrifuged at 14,000 rpm
for 5min. The supernatant was collected and further propagated
by adding 100µL of the phage supernatant and 100µL (OD600
of 1.0) of S. aureus RN10950 to 3mL of top agar. The mix-
ture was poured onto phage bottom agar plates and incubated
at 32◦C for 24 h. The top agar was collected and centrifuged at
7500 rpm for 15min. The supernatant was collected and filtered
sequentially through 0.45µm filters and 0.22µm filters. The
propagation step was repeated until complete lysis was observed.
Supernatants then were purified on a cesium chloride gradi-
ent according to previously described protocols for isolation of
viruses (Pride et al., 2012). Only the fraction with a density corre-
sponding tomost known bacteriophage (Murphy et al., 1995) was
retained, further purified on Amicon YM-100 protein purifica-
tion columns (Millipore, Inc., Bellerica, MA), treated with DNase
I, and subjected to lysis and DNA purification using the Qiagen
UltraSens virus kit (Qiagen, Valencia, CA). Resulting DNA was
fragmented to roughly 200 to 400 bp using a Bioruptor (Diagen-
ode, Denville, NJ), and utilized as input to create libraries using
the Ion Plus Fragment Library Kit according to manufacturer’s
instructions. Libraries then were sequenced using a 314 chip on
an Ion Torrent Personal Genome Machine (PGM; Life Tech-
nologies, Grand Island, NY) (Rothberg et al., 2011) producing
an average read length of approximately 216 bp for each sam-
ple. Sequence reads were trimmed according to modified Phred
scores of 0.5 using CLC Genomics Workbench 4.65 (CLC bio
USA, Cambridge, MA). Any low complexity reads (where >25%
of the length were due to homopolymer tracts), reads with sub-
stantial length variation (<50 nucleotides or >300 nucleotides),
or reads with ambiguous characters also were removed prior to
further analysis. Remaining reads were assembled using CLC
Genomics Workbench 4.65 based on 98% identity with a mini-
mum of 50% read overlap, which are more stringent than criteria
developed to discriminate between highly related viruses (Bre-
itbart et al., 2002). The consensus sequence for each assembled
phage was constructed according to majority rule. Viral con-
tigs were analyzed using FGenesV (Softberry Inc, Mount Kisco,
NY) for ORF prediction, and individual ORFs analyzed using
BLASTP analysis against the NCBI non-redundant database
(Escore <10−5). Alignments of phage genomes were performed
with progressiveMauve using the default settings (Darling et al.,
2010). Sequences of each Staphylococcus phage are available in
Genbank under accession numbers KJ452291 and KJ452292. The
reverse complements of these phage genome sequences were
utilized in the genome alignments.
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Supplemental Figure 1 | Growth curves for MRSA isolates. Each isolate is
shown in separate panels with their respective OD600 measurements at 15min
intervals on the y-axis and the time over a period of 24 h period shown on the
x-axis. The time of fluorescence detection under in vitro (blue circles) and ex vivo
(red circles) conditions are shown for each subject in each panel.
Supplemental Figure 2 | Mean percentage (± standard deviation) of all
gene expression from each subsystem in Staphylococcus aureus
transcriptomes ex vivo and in vitro. The upper panel shows subsystems that
were significantly different between ex vivo and in vitro samples, and the lower
panel shows subsystems that were not significantly different. p-values are shown
to the right of each subsystem. Ex vivo gene expression is represented by black
bars and in vitro is represented by white bars.
Supplemental Figure 3 | Abundance (%) of mobile element gene
expression in Staphylococcus aureus transcriptomes for all subjects.
Specimens 21MRA and 23MRA are from the same subject 48 h apart.
Supplemental Figure 4 | Abundance (%) of virulence gene expression
in Staphylococcus aureus transcriptomes for all subjects. Ex vivo
gene expression is represented by black bars and in vitro is represented by
white bars. Specimens 21MRA and 23MRA are from the same subject
48 h apart.
Supplemental Figure 5 | Mean percentage (± standard deviation) of the
virulence subsystem devoted to individual elements. p-values are shown
above each virulence factor. Ex vivo gene expression is represented by black bars
and in vitro is represented by white bars. (A) shows Staphylococcal Pathogenicity
Islands (SaPIs) and cytolysins, and (B) shows tcaA (teicoplanin-resistance), ddl
(involved in cell wall synthesis) and lukS-PV and lukF-PV (encoding
Panton-Valentine leukocidin).
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